相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
Anjali Sharma et al.
SCIENCE ADVANCES (2020)
Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury
Rishi Sharma et al.
JOURNAL OF CONTROLLED RELEASE (2020)
In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects
Victoria Osinski et al.
THERANOSTICS (2020)
Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration
Kevin Liaw et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2020)
Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease
Gifty M. Jojo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Inactive ingredients in oral medications
Daniel Reker et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders
Elizabeth S. Smith et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning
Eliseos J. Mucaki et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model
Anjali Sharma et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Quantitative assessment of surface functionality effects on microglial uptake and retention of PAMAM dendrimers
Kevin Liaw et al.
JOURNAL OF NANOPARTICLE RESEARCH (2018)
Polarization of Microglia to the M2 Phenotype in a Peroxisome Proliferator-Activated Receptor Gamma-Dependent Manner Attenuates Axonal Injury Induced by Traumatic Brain Injury in Mice
Liang Wen et al.
JOURNAL OF NEUROTRAUMA (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Wei Cai et al.
PROGRESS IN NEUROBIOLOGY (2018)
Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration
Christina Ising et al.
CELL DEATH & DISEASE (2018)
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Claudio Soto et al.
NATURE NEUROSCIENCE (2018)
The Kaleidoscope of Microglial Phenotypes
Marissa L. Dubbelaar et al.
FRONTIERS IN IMMUNOLOGY (2018)
New Advances in General Biomedical Applications of PAMAM Dendrimers
Renan Vinicius de Araujo et al.
MOLECULES (2018)
Cognitive impairments induced by necrotizing enterocolitis can be prevented by inhibiting microglial activation in mouse brain
Diego F. Nino et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation
Rishi Sharma et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2018)
Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics
Anjali Sharma et al.
THERANOSTICS (2018)
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Susanne Krasemann et al.
IMMUNITY (2017)
Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome
Elizabeth Nance et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Glitazone Use Associated With Reduced Risk of Parkinson's Disease
Brage Brakedal et al.
MOVEMENT DISORDERS (2017)
Microglia emerge as central players in brain disease
Michael W. Salter et al.
NATURE MEDICINE (2017)
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease
Sudhakar R. Subramaniam et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation
Rishi Sharma et al.
BIOCONJUGATE CHEMISTRY (2017)
Dendrimers Effects on the Immune System: Insights into Toxicity and Therapeutic Utility
Marina A. Dobrovolskaia
CURRENT PHARMACEUTICAL DESIGN (2017)
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Yu Tang et al.
MOLECULAR NEUROBIOLOGY (2016)
Nanotechnology Approaches to Targeting Inflammation and Excitotoxicity in a Canine Model of Hypothermic Circulatory Arrest-Induced Brain Injury
Joshua C. Grimm et al.
ANNALS OF THORACIC SURGERY (2016)
Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice
Soichi Nakashiro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Nanoscale effects in dendrimer-mediated targeting of neuroinflammation
Elizabeth Nance et al.
BIOMATERIALS (2016)
The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes
Qiuying Zhao et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Anti-Inflammatory Effects of Ginsenoside-Rh2 Inhibits LPS-Induced Activation of Microglia and Overproduction of Inflammatory Mediators Via Modulation of TGF-β1/Smad Pathway
R. Vinoth Kumar et al.
NEUROCHEMICAL RESEARCH (2016)
Dendrimers Target the Ischemic Lesion in Rodent and Primate Models of Nonarteritic Anterior Ischemic Optic Neuropathy
Yan Guo et al.
PLOS ONE (2016)
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation
Anja Henn
ALTEX-Alternatives to Animal Experimentation (2016)
Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers
Fan Zhang et al.
BIOMATERIALS (2015)
NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. (vol 14, pg 795, 2015)
Chadwick W. Christine
LANCET NEUROLOGY (2015)
Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner
Sandeep K. Sharma et al.
SCIENTIFIC REPORTS (2015)
Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease
Marta Esteves et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Regulation of macrophage, dendritic cell, and microglial phenotype and function by the SOCS proteins
Sarah M. McCormick et al.
FRONTIERS IN IMMUNOLOGY (2015)
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Tanya Simuni et al.
LANCET NEUROLOGY (2015)
Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest
Manoj K. Mishra et al.
ACS NANO (2014)
Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus The AleCardio Randomized Clinical Trial
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Neuroinflammation and M2 microglia: the good, the bad, and the inflamed
Jonathan D. Cherry et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Fetal uptake of intra-amniotically delivered dendrimers in a mouse model of intrauterine inflammation and preterm birth
Irina Burd et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Microglial priming in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
A comparative review of toll-like receptor 4 expression and functionality in different animal species
Celine Vaure et al.
FRONTIERS IN IMMUNOLOGY (2014)
Selective Nanovector Mediated Treatment of Activated Proinflammatory Microglia/Macrophages in Spinal Cord Injury
Simonetta Papa et al.
ACS NANO (2013)
Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity
Daniele Di Mascolo et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Microglia Response and In Vivo Therapeutic Potential of Methylprednisolone-Loaded Dendrimer Nanoparticles in Spinal Cord Injury
Susana R. Cerqueira et al.
SMALL (2013)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Selective targeting of microglia by quantum dots
S. Sakura Minami et al.
JOURNAL OF NEUROINFLAMMATION (2012)
PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice
Mitsugu Yamanaka et al.
JOURNAL OF NEUROSCIENCE (2012)
Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
Shweta Mandrekar-Colucci et al.
JOURNAL OF NEUROSCIENCE (2012)
A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
Luc Dupuis et al.
PLOS ONE (2012)
Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model
Sujatha Kannan et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Lysosomal pH and analysis of the counter ion pathways that support acidification
Jessica E. DiCiccio et al.
JOURNAL OF GENERAL PHYSIOLOGY (2011)
Repertoire of microglial and macrophage responses after spinal cord injury
Samuel David et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Divergent Synthesis of Hydrophilic Dendrons Based on Tri(ethylene glycol) Spacers
Jie Song et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2010)
The effect of surface functionality on cellular trafficking of dendrimers
Omathanu P. Perumal et al.
BIOMATERIALS (2008)
Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice
Suzanne E. Hickman et al.
JOURNAL OF NEUROSCIENCE (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Effect of tesaglitazar, a dual PPARα/γ agonist, on glucose and lipid abnormalities in patients with type 2 diabetes:: a 12-week dose-ranging trial
Barry J. Goldstein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Agonists for the peroxisome proliferator-activated receptor-α and the retffionid X receptor inhibit inflammatory responses of microglia
JH Xu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
MA Leissring et al.
NEURON (2003)
AZ 242, a novel PPARα/-γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats
B Ljung et al.
JOURNAL OF LIPID RESEARCH (2002)
Role of the peroxisome proliferator-activated receptor-γ (PPAR-γ) and its natural ligand 15-deoxy-Δ12,14-prostaglandin J2 in the regulation of microglial functions
A Bernardo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)